Software giant SAP, British AI startup BenevolentAI and the University of Reims Champagne-Ardenne have become Europe’s first users of our new NVIDIA DGX-1 AI supercomputer.
This “plug and play” system — loaded with powerful GPUs and special software for deep learning — has been designed to help data scientists innovate and get to market faster with AI applications.
Enterprise software giant SAP is now using DGX-1 AI supercomputers at its German and Israeli offices, where its teams are building machine learning solutions for SAP’s 320,000 customers.
In the U.K., BenevolentAI will use DGX-1 as part of its effort to accelerate drug discovery by using deep natural language processing, machine learning and artificial intelligence to formulate new, usable knowledge from complex scientific information.
“For the current application of our AI technology in the bioscience space, it will mean that new drug discoveries can be made faster and more efficiently than ever before,” said BenevolentAI co-founder and Director Ken Mulvany.
In France, DGX-1 will help the team at the University of Reims Champagne-Ardenne’s ROMEO high performance computing center use deep learning to help prevent or cure diseases affecting grapevines.
“Thanks to this new outstanding technology, our university will be able to contribute actively to the economic development of our region,” said URCA President Guillaume Gellé. “Not to mention helping to ensure the health of our most famous export: champagne.”